The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

For many people with psoriasis ... easier to remove. (Urea and lactic acid work the same way.) 2. Try a Parting of the Ways When applying a product, part your hair to expose your scalp so ...

“They leave it out of the discussion,” he says. “For patients who have the most common type of psoriasis, plaque psoriasis, there is not a clear, established relationship with thyroid ...

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...

The National Institute for Health and Care Excellence (NICE) has backed the use of the first-in-class Tyk2 inhibitor as an option for treating adults with moderate to severe plaque psoriasis who ...

Gray. Purple. Brown. Scales and skin flakes caused by plaque psoriasis are usually silver on darker skin tones. Will Scalp Psoriasis Affect My Hair Growth? Plaques can develop on your scalp and ...